Theravance Biopharma, Inc. (TBPH)
17.07
-0.01
(-0.06%)
USD |
NASDAQ |
Sep 04, 12:02
Theravance Biopharma Net Income (Annual) : 105.90M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 105.90M |
| December 31, 2024 | -56.42M |
| December 31, 2023 | -55.19M |
| December 31, 2022 | -92.82M |
| December 31, 2021 | -265.07M |
| December 31, 2020 | -278.02M |
| December 31, 2019 | -236.46M |
| December 31, 2018 | -215.52M |
| Date | Value |
|---|---|
| December 31, 2017 | -285.40M |
| December 31, 2016 | -190.67M |
| December 31, 2015 | -182.22M |
| December 31, 2014 | -237.04M |
| December 31, 2013 | -156.28M |
| December 31, 2012 | -9.575M |
| December 31, 2011 | -109.34M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Zymeworks, Inc. | -81.13M |
| Viatris, Inc. | -3.515B |
| Ocular Therapeutix, Inc. | -265.94M |
| ANI Pharmaceuticals, Inc. | 71.37M |
| Corcept Therapeutics, Inc. | 98.17M |